Profile data is unavailable for this security.
About the company
Shenzhen Neptunus Interlong Bio-Technique Company Limited is a Hong Kong-based company principally engaged in the development, production and sales of medicines. The Company operates through three segments. Medicines segment is engaged in the manufacture and sales of medicines. Medicines and Healthcare Products segment is engaged in the sales and distribution of medicines and healthcare products. Research and Development Services of Modern Biological Technology segment is engaged in the provision of research and development services of modern biological technologies, such as in vitro diagnostics reagents businesses. The products of the Company include herbal medicines, generic drugs, transfusion and anti-tumor drugs, among others. The Company mainly operates businesses in China.
- Revenue in HKD (TTM)1.13bn
- Net income in HKD29.36m
- Incorporated1994
- Employees1.44k
- LocationShenzhen Neptunus Interlong Bio-technique Co Ltd1F, Block 1, Research BuildingNeptunus Technical CenterSHENZHEN 518000ChinaCHN
- Phone+86 75 526411869
- Fax+86 75 586391610
- Websitehttps://www.interlong.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Extrawell Pharmaceutical Holdings Ltd | 68.62m | -154.28m | 93.21m | 169.00 | -- | 0.0896 | -- | 1.36 | -0.0776 | -0.0776 | 0.0209 | 0.4354 | 0.0538 | 7.47 | 9.89 | 379,132.60 | -12.00 | 4.62 | -12.50 | 4.88 | 47.36 | 51.97 | -223.07 | 73.99 | 3.38 | -0.0514 | 0.0968 | 0.00 | -1.82 | -3.28 | -1.01 | 33.99 | 121.54 | -- |
| Sanai Health Industry Group Co Ltd | 131.98m | 20.14m | 103.21m | 68.00 | 4.88 | 0.3032 | 5.79 | 0.782 | 0.0055 | 0.0055 | 0.0348 | 0.089 | 0.3179 | 188.03 | 8.44 | 1,940,931.00 | 3.48 | 2.31 | 4.72 | 3.65 | 28.77 | 34.87 | 10.95 | 6.56 | 6.22 | -- | 0.1881 | 0.00 | -30.60 | 16.04 | -36.23 | -- | -75.21 | -- |
| China Health Group Inc | 23.16m | -62.92m | 111.48m | 42.00 | -- | 1.22 | -- | 4.81 | -0.0632 | -0.0632 | 0.0233 | 0.0921 | 0.1438 | -- | 0.246 | 551,419.30 | -39.07 | 6.84 | -51.26 | 9.52 | 38.33 | 74.98 | -271.70 | 19.19 | -- | -- | 0.00 | 0.00 | 63.67 | -18.51 | -267.82 | -- | 30.37 | -- |
| BioSino Bio-technology and Science Inc | 312.48m | -12.59m | 123.00m | 537.00 | -- | 0.5409 | -- | 0.3936 | -0.087 | -0.087 | 2.16 | 1.57 | 0.4956 | 2.79 | 1.46 | 581,893.60 | -3.30 | -3.84 | -8.55 | -10.17 | 44.06 | 40.17 | -6.66 | -6.98 | 0.9033 | -- | 0.3956 | -- | -22.52 | -0.9513 | -243.70 | -- | -16.58 | -- |
| Canbridge Pharmaceuticals Inc | 111.20m | -409.51m | 144.45m | 100.00 | -- | -- | -- | 1.30 | -0.965 | -0.965 | 0.262 | -0.1013 | 0.1875 | 4.16 | 4.09 | 1,111,996.00 | -69.04 | -- | -154.20 | -- | 62.37 | -- | -368.26 | -- | 0.6132 | -41.34 | 1.39 | -- | 30.26 | -- | 21.64 | -- | -- | -- |
| Regent Pacific Group Ltd | 2.48m | -195.82m | 148.46m | 17.00 | -- | -- | -- | 59.91 | -0.8698 | -0.8698 | 0.011 | -0.0531 | 0.0218 | -- | 12.19 | 145,769.70 | -172.08 | -50.00 | -694.26 | -59.04 | -- | -- | -7,901.89 | -2,685.21 | -- | -- | -- | -- | 574.47 | -44.72 | 31.24 | -- | -50.60 | -- |
| Kontafarma China Holdings Ltd | 809.11m | -28.84m | 184.42m | 720.00 | -- | 0.1744 | 4.17 | 0.2279 | -0.0052 | -0.0052 | 0.145 | 0.1892 | 0.4206 | 3.22 | 7.03 | 1,123,760.00 | -3.18 | -1.33 | -4.22 | -2.18 | 58.25 | 54.70 | -7.55 | -4.12 | 1.28 | -17.16 | 0.2392 | -- | -9.50 | -17.32 | 66.02 | -- | -19.55 | -- |
| Modern Chinese Medicine Group Co Ltd | 371.93m | 52.75m | 225.00m | 191.00 | 4.27 | 0.4402 | 3.79 | 0.605 | 0.0879 | 0.0879 | 0.6199 | 0.852 | 0.6681 | 5.45 | 3.80 | 1,947,288.00 | 9.47 | 20.76 | 10.75 | 25.82 | 30.28 | 41.02 | 14.18 | 20.11 | 7.98 | 206.12 | 0.0002 | 2.54 | -13.91 | 14.67 | -44.44 | 0.2303 | 96.96 | -- |
| Wai Yuen Tong Medicine Holdings Limited | 1.36bn | 36.42m | 252.02m | 1.96k | 7.40 | 0.1179 | 1.47 | 0.1854 | 0.0303 | 0.0303 | 1.13 | 1.90 | 0.2014 | 0.424 | 22.81 | 700,208.60 | 0.8907 | -0.0733 | 1.54 | -0.1196 | 49.08 | 42.52 | 4.42 | -0.456 | 0.5663 | 1.49 | 0.3196 | 0.00 | -7.55 | 8.75 | 81.16 | -- | -12.06 | -- |
| Shenzhen Neptunus Intrlng Bi tchnq CoLtd | 1.13bn | 29.36m | 253.38m | 1.44k | 8.63 | -- | 11.57 | 0.2242 | 0.0175 | 0.0175 | 0.6735 | -- | -- | -- | -- | 782,628.40 | -- | 3.46 | -- | 5.13 | 39.48 | 49.14 | 1.46 | 4.29 | -- | 109.94 | -- | 0.00 | 7.92 | 4.19 | -55.60 | -12.89 | -11.10 | -- |
| PuraPharm Corp Ltd | 406.86m | -106.08m | 292.96m | 662.00 | -- | 1.91 | -- | 0.7201 | -0.2685 | -0.2685 | 1.03 | 0.3871 | 0.4374 | 1.04 | 4.21 | 614,590.60 | -11.40 | -9.20 | -34.00 | -19.70 | 53.24 | 59.52 | -26.07 | -19.33 | 0.3046 | -2.02 | 0.7349 | -- | -9.20 | -11.41 | 11.76 | -- | -13.68 | -- |
| Hin Sang Group (Interntnl) Hldng Co Ltd | 92.79m | -35.72m | 311.16m | 265.00 | -- | 1.41 | -- | 3.35 | -0.0327 | -0.0327 | 0.085 | 0.202 | 0.1524 | 2.29 | 9.49 | 366,766.80 | -5.81 | -4.06 | -8.74 | -5.26 | 55.95 | 61.98 | -38.14 | -20.98 | 0.1129 | -1.15 | 0.5766 | -- | -32.42 | -15.45 | -315.54 | -- | -36.30 | -- |
Data as of May 31 2024. Currency figures normalised to Shenzhen Neptunus Interlong Bio-technique Co Ltd's reporting currency: Hong Kong Dollar HKD
0.02%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Invesense Asset Management Ltd.as of 30 Apr 2024 | 80.00k | 0.02% |
Data from 30 Apr 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.
